On December 15, 2017, The Procter & Gamble Company issued an open letter to shareholders announcing certified results of its 2017 annual meeting of shareholders, including Director elections and actions the Board is taking based on shareholder input. The company stated that based on the certified count, shareholders have elected all 11 of Company’s Directors to the Board and added that because the election results were so close, and because a large number of shareholders voted for Nelson Peltz to be a Director, the Board has engaged in numerous discussions with Nelson Peltz regarding a Board seat. Further, the company added in the letter that the Board has increased the size of the Board from 11 to 13 Directors and appointed Joseph Jimenez, Chief Executive Officer of Novartis AG, and Nelson Peltz, Chief Executive Officer of Trian Fund Management, L.P., as a Director of the Company, effective March 1, 2018.